7Baggers
 relmada therapeutics reports q3 2025 financial results  MSN Sun, 16 Nov 2025 07:27:10 GMT
 relmada shares defy positive results with sharp decline  AD HOC NEWS Fri, 14 Nov 2025 12:09:04 GMT
 Relmada Therapeutics Reports Q3 2025 Financial Results  TipRanks Fri, 14 Nov 2025 04:47:11 GMT
 relmada (rlmd) q3 2025 earnings call transcript  AOL.com Thu, 13 Nov 2025 22:53:23 GMT
 Relmada Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 22:36:25 GMT
 Relmada Therapeutics (RLMD) Tops Q3 EPS by 15c  StreetInsider Thu, 13 Nov 2025 21:33:12 GMT
 Relmada Therapeutics Q3 net loss narrows  MarketScreener Thu, 13 Nov 2025 21:21:08 GMT
 A Glimpse of Relmada Therapeutics's Earnings Potential  Benzinga Wed, 12 Nov 2025 18:02:45 GMT
 Relmada therapeutics (RLMD) CEO Sergio Traversa buys $599k in stock  Investing.com Canada Fri, 07 Nov 2025 07:14:34 GMT
 relmada therapeutics executives make bold stock purchases!  TipRanks Fri, 07 Nov 2025 02:19:09 GMT
 Relmada Therapeutics Stock (RLMD) Opinions on FDA Feedback and Insider Activity  Quiver Quantitative Thu, 06 Nov 2025 14:06:00 GMT
 Ence Chuck, Relmada Therapeutics CAO, buys $299k in RLMD stock  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Relmada therapeutics (RLMD) CEO Sergio Traversa buys $599k in stock  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Shenouda, Relmada Therapeutics CFO, buys $1.1m in RLMD  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Relmada Therapeutics (RLMD) COO Kelly buys $198,000 in stock  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Insider Buying: Chuck Ence Acquires 136,000 Shares of Relmada Th  GuruFocus Thu, 06 Nov 2025 08:00:00 GMT
 relmada therapeutics prices $100m securities offering  MSN Wed, 05 Nov 2025 15:59:50 GMT
 relmada’s ndv-01 shows 92% response rate in bladder cancer by investing.com  Investing.com Nigeria Wed, 05 Nov 2025 08:17:21 GMT
 Relmada Therapeutics Leads These 3 Promising Penny Stocks  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Lowenstein Represents Relmada in $100M Underwritten Stock Offering  Lowenstein Sandler LLP Wed, 05 Nov 2025 08:00:00 GMT
 Relmada Therapeutics Announces $100M Stock Offering  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 Relmada Therapeutics (RLMD) Advances Phase 3 Plans for Bladder C  GuruFocus Tue, 04 Nov 2025 17:40:27 GMT
 relmada therapeutics prices $100m securities offering  MSN Tue, 04 Nov 2025 13:51:37 GMT
 Relmada Therapeutics (RLMD) Launches $100 Million Stock and Warr  GuruFocus Tue, 04 Nov 2025 13:47:22 GMT
 relmada’s ndv-01 shows 92% response rate in bladder cancer  Investing.com Tue, 04 Nov 2025 12:35:25 GMT
 relmada therapeutics receives fda feedback on ndv-01 trials  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 relmada therapeutics moves: max kates joins advisory board  StocksToTrade Tue, 04 Nov 2025 08:00:00 GMT
 relmada therapeutics announces $100m stock offering  MSN Tue, 04 Nov 2025 08:00:00 GMT
 relmada therapeutics, inc. (nasdaq:rlmd) short interest update  MarketBeat Mon, 03 Nov 2025 13:15:30 GMT
 what to expect from relmada therapeutics inc. in the next 30 days  newser.com Mon, 03 Nov 2025 12:18:48 GMT

Relmada Therapeutics, Inc
(NASDAQ:RLMD) 

RLMD stock logo

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of de...

Founded: 2004
Full Time Employees: 6
CEO: Sergio Traversa  
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends